Related Experiment Video
Updated: Oct 18, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Membranous nephropathy
Pierre Ronco1,2, Laurence Beck3, Hanna Debiec4
1Sorbonne Université, and Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche, S1155, Paris, France. pierreronco@yahoo.fr.
Abstract:
Membranous nephropathy (MN) is a glomerular disease that can occur at all ages. In adults, it is the most frequent cause of nephrotic syndrome. In ~80% of patients, there is no underlying cause of MN (primary MN) and the remaining cases are associated with medications or other diseases such as systemic lupus erythematosus, hepatitis virus infection or malignancies. MN is an autoimmune disease characterized by a thickening of the glomerular capillary walls due to immune complex deposition. Identification of the phospholipase A2 receptor (PLA2R) as the major antigen in adults in 2009 induced a paradigm shift in disease diagnosis and monitoring and several other antigens have since been characterized. Disease outcome is difficult to predict and around one-third of patients will undergo spontaneous remission. In those at high risk of progression, immunosuppressive therapy with cyclophosphamide plus corticosteroids has substantially reduced the need for kidney replacement therapy. Owing to carcinogenic risk, other treatments (calcineurin inhibitors and CD20-targeted B cell depletion therapy (rituximab)) have been developed. However, disease relapses are frequent when calcineurin inhibitors are stopped and the remission rate with rituximab is lower than with cyclophosphamide, particularly in patients with high PLA2R antibody titres. Other new drugs are already available and antigen-specific immunotherapies are being developed.
Insights
Membranous nephropathy (MN) is an autoimmune kidney disease. New treatments targeting phospholipase A2 receptor (PLA2R) offer improved outcomes, but relapses and risks necessitate ongoing research for better therapies.
Area of Science:
- Nephrology
- Immunology
- Autoimmune Diseases
Background:
- Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults.
- Primary MN accounts for ~80% of cases, while secondary MN is linked to infections, malignancies, or medications.
- MN is characterized by immune complex deposition in glomerular capillary walls, indicating an autoimmune basis.
Purpose of the Study:
- To review the current understanding of membranous nephropathy (MN).
- To discuss the diagnostic paradigm shift following the identification of phospholipase A2 receptor (PLA2R) as a key antigen.
- To summarize current and emerging therapeutic strategies for MN.
Main Methods:
- Review of existing literature on membranous nephropathy.
- Analysis of diagnostic advancements, particularly antigen identification (e.g., PLA2R).
- Evaluation of therapeutic outcomes for immunosuppressive agents and novel treatments.
Main Results:
- Identification of PLA2R as the primary antigen in adult MN revolutionized diagnosis and monitoring.
- Immunosuppressive therapy (cyclophosphamide/corticosteroids) reduces progression to kidney failure.
- Alternative treatments like calcineurin inhibitors and rituximab have limitations such as relapse rates and efficacy in high-antibody patients.
Conclusions:
- Membranous nephropathy (MN) management has advanced significantly with antigen identification and targeted therapies.
- While current treatments improve outcomes, challenges like frequent relapses and side effects persist.
- Ongoing research into novel drugs and antigen-specific immunotherapies holds promise for improved MN patient care.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrons
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome II : Assessment and Medical Management
Glomerular Filtration
Components of the Filtration Membrane
The filtration process involves three key layers: the glomerular endothelial cells, the basement membrane, and the podocyte-formed filtration slits.
Acute Kidney Injury II: Pathophysiology

